Blepharoplasty Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type, by Gender, by Service Provider : Global Opportunity Analysis and Industry Forecast, 2022-2031

Blepharoplasty Market Research, 2031

The global blepharoplasty market size was valued at $3.4 billion in 2021, and is projected to reach $7.2 billion by 2031, growing at a CAGR of 7.6% from 2022 to 2031. Blepharoplasty, also known as eyelid surgery, is a cosmetic procedure that involves the reshaping or removal of excess skin, fat, or muscle from the eyelids. It is often performed to improve the appearance of the eyes and to look more youthful. In some cases, blepharoplasty may be done to treat medical conditions such as droopy eyelids that can cause vision problems. The goal of the procedure is to create a smoother and more youthful appearance. It is typically done under local anesthesia. During the procedure, the surgeon makes incisions in the eyelids and removes the excess tissue. The incisions are then closed with sutures. After the procedure, patients may experience some swelling and bruising around the eyes, but these should go away within a few days. The procedure can be performed on the upper eyelids, lower eyelids, or both. It is done to enhance the appearance of the eyelids and correct any functional problems caused by excess skin, such as vision obstruction or difficulty keeping the eyes open.         

Historical overview 

The blepharoplasty market size was analyzed qualitatively and quantitatively from 2018-2020. Most of the growth during this period was derived from the Asia-Pacific region owing to the increasing aging population, rising demand for cosmetic surgery, gaining popularity of blepharoplasty as a medical treatment, improving health awareness, rising disposable incomes, as well as the well-established presence of hospitals & clinics for blepharoplasty surgery in the region.  

Market dynamics 

The rise in the prevalence of vision impairment due to rising geriatric population, and rising demand for blepharoplasty propel the blepharoplasty market growth. In addition, the increase in the prevalence of vision impairment due to condition such as dermatochalasis drives the market growth. Dermatochalasis leads to difficulties in primary sight, reading, and visual functions due to visual field defects. In addition, lower eyelid sagginess, causes the lower lashes to rub against the eye, leading to irritation, redness, and even damage to the cornea. These conditions cause fewer visual sights and more mobility impairment in geriatric population. For instance, according to case study reported in “Journal of Ophthalmology”, in April 2020, 30% of the population aged 65 and older die or become permanently disabled due to falling once a year or more. In addition, as per the same source, every 10% loss in visual field corresponds to an 8% higher risk of falls in adults older than 65 years. Thus, rise in the prevalence of risk associated with dermatochalasis and indirectly increase in mobility impairment in geriatric population due to excessive accumulation of fat in upper eyelid are expected to propel the growth of blepharoplasty market during forecast period.   

Moreover, the availability of improved facilities and the growing demand for cosmetic surgery from the large millennial and geriatric population and rise in the adoption of innovative techniques and devices is fueling the market growth. The demand for blepharoplasty surgery is not only limited to developed countries but is also being witnessed in developing countries, owing to the rapid increase in geriatric populations of countries like China, Brazil, and India, which fuel the growth of the market. Furthermore, increase in the celebrity population and urge to look beautiful irrespective of gender has increased the need for cosmetic surgeries such as rhinoplasty, abdominoplasty, blepharoplasty, and others, which further drives the market growth. For instance, according to the American Society of Plastic Surgeons, in 2020, approximately 85% of blepharoplasty procedures were performed on women, and 15% were performed on men. Overall, the increase in adoption of cosmetic surgery can be seen as an blepharoplasty market opportunity, as more people become interested in enhancing their appearance and correcting functional problems caused by excess skin and fat around the eyes.     

The outbreak of COVID-19 has disrupted workflows in the healthcare sector around the world. The COVID-19 pandemic has had a major impact on blepharoplasty surgery. Many countries across the world have implemented strict lockdowns and social distancing protocols, which have disrupted access to healthcare services and reduced the number of patients opting for blepharoplasty.  

In addition, some countries have placed restrictions on elective surgeries, which has further limited the availability of blepharoplasty services. Moreover, the pandemic has caused a shortage of protective equipment, such as face masks and gloves, which are essential for blepharoplasty surgeries. As a result, many surgeons are providing fewer blepharoplasty services than they did prior to the pandemic. Furthermore, the pandemic has had a major economic impact on many countries, leading to decreased disposable incomes and reduced spending on elective surgeries, including blepharoplasty. This has resulted in a decrease in the number of blepharoplasty surgeries being performed.

However, rise in vaccination and increase in demand of eyelid rejuvenation is expected to contribute to moderate growth of market. In addition, with COVID appropriate protocols, blepharoplasty surgeries are being performed which impacts the growth of market positively. For instance, according to report of International Society of Aesthetic Plastic Surgery in 2021 there was 18.1% rise in eyelid surgeries as compared to 2020. Thus, blepharoplasty industry has observed moderate growth in 2021 and is expected to provide lucrative growth opportunities during the forecast period.        

Segmental Overview 

The blepharoplasty market share is segmented on the basis of type, gender and service provider. On the basis of type the market is segmented into upper eyelid surgery, lower eyelid surgery and combination eyelid surgery. On the basis gender, the market is divided into female and male. On the basis of service provider, market is divided into hospital, clinics, and ambulatory surgical centers. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).  

By Type

The blepharoplasty market share based on type is segmented into upper eyelid surgery, lower eyelid surgery and combination eyelid surgery. The upper eyelid surgery segment dominated the global market in 2021 and is expected to remain dominant throughout the forecast period, owing to the fact that most of the patient prefer upper eyelid surgery because it offers improved vision, less double vision, and a more youthful appearance. However, lower eyelid surgery segment is expected to witness considerable market growth during the forecast period, owing to the rise in geriatric population and growth in demand for non-invasive surgical procedures which helps to reduce the excessive fats under the eyes are the factors that propel the growth of the market. .  

By Gender

By gender the market is bifurcated into female and male. The female segment dominated the global market in 2021 and is anticipated to continue this trend during the forecast period. This is attributed to rising desire to improve the appearance by rejuvenate the appearance of the eyes, making eyes look more youthful and refreshed. However, male segment is expected to witness considerable market growth during the forecast period, owing to rise in awareness among men to enhance the appearance, increases the demand for blepharoplasty surgery.  

By Service Provider

BHy service provider the market is segmented into hospitals, clinics, and ambulatory surgical centers. The hospitals segment dominated the global market in 2021 and is anticipated to continue this trend during the forecast period. This is attributed to owing to, increase in the number of hospitals providing surgical procedures for eyelid with the help of technologically advanced medical devices and rise in the number of patients undergoing cosmetical surgeries from hospital facilities. However, clinics segment is expected to witness considerable market growth during the forecast period. This is attributed to the availability of advanced equipment and well-trained healthcare staff.

By Region

By region the blepharoplasty market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the blepharoplasty market in 2021 and is expected to maintain its dominance during the forecast period. The presence of several major key players and the rising advancement in technology of medical devices in this region drive the growth of the market. The increase in the number of people undergoing blepharoplasty procedures to improve appearance of eyes with the help of new and advanced cosmetic procedures such as laser resurfacing and dermal fillers are the key factor attributing to the growth of the market. For instance, according to report published by International Society of Aesthetic Plastic Surgery in 2021, it has been estimated that a total of 149,668 eyelid Surgery procedures were performed in the U.S. whereas 53,253 numbers of eyelid surgery were performed in Mexico in 2021. 

Asia-Pacific is expected to grow at the highest rate during the forecast period. The market growth in this region is attributable to the presence of pharmaceutical medical device manufacturers in the region as well as the rise in the geriatric population of the countries, such as China and India. increase in the number of geriatric populations, and the rise in population experiencing baggy or droopy upper eyelids due to sedentary lifestyles, more screen time owing to covid-19 pandemic. For instance, according to report published by International Society of Aesthetic Plastic Surgery in 2021, a total of 24,480 eyelid surgery in India and 152,852 surgeries in Japan were performed.  Moreover, the increasing preference for minimally invasive surgeries is estimated to bring growth opportunities over the forecast period for blepharoplasty market. In many Asian countries, double eyelid surgery is the most popular surgery, especially in Korea.

COMPETITION ANALYSIS 

Competitive analysis and profiles of the major players in the blepharoplasty industry, are Sisram Medical Ltd, Abbvie Inc ,LightScalpel ,Lumenis , Grand Aespio Inc., Medtronic plc, Surgical Holdings Ltd., Medline industries, inc., London Bridge Plastic Surgery, M A Corporation.   

Key Strategy 

In October 2020, Allergan Aesthetics, an AbbVie company, entered into an agreement with Luminera, a privately held, aesthetics company with a portfolio and pipeline of dermal filler products. This agreement will enhance the dermal filler portfolio of the company in International and US markets.   

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the blepharoplasty market analysis from 2021 to 2031 to identify the prevailing blepharoplasty market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the blepharoplasty market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global blepharoplasty market trends, key players, market segments, application areas, and market growth strategies.

  Blepharoplasty Market Report Highlights

Aspects	Details
Market Size By 2031	USD 7.2 billion
Growth Rate	CAGR of 7.6%
Forecast period	2021 - 2031
Report Pages	232
By Type	Upper Eyelid Blepharoplasty Lower Eyelid Blepharoplasty Combination Eyelid Surgery
By Gender	Female Male
By Service Provider	Hospitals Clinics Ambulatory Surgical Centre
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific) LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players	Abbvie Inc, Grand Aespio Inc., Surgical Holdings Ltd., London Bridge Plastic Surgery, M A Corporation, Medline industries, inc., LightScalpel, Medtronic plc, Lumenis, Sisram Medical Ltd

Analyst Review

According to the insights of CXOs, increase in demand to enhance the aesthetic appeal of eyes by correcting baggy eyelids, droopy eyelids, and other eyelid defects & disfigurations and increase in demand for non-surgical technologies for eyelid surgery, globally is expected to offer profitable opportunities for the expansion of the market. In addition, favorable government regulations and higher spending for cosmetic surgeries to develop novel methods for blepharoplasty, boost the growth of the market.  

CXOs further added that rise in expenditure on the development of healthcare infrastructure and rise in personal disposable income is expected to boost the growth of blepharoplasty market. In addition, increase in desire to improve appearance without undergoing a full facelift has resulted rise in demand for minimally invasive procedures, which drive the growth of market. Furthermore, geriatric people are prone to visual defects due to drooping eyelids, thus rise in number of geriatric populations is anticipated to drive the growth of market.  

North America has the highest market share in 2021 and is expected to maintain its lead during the forecast period, owing to the availability of improved facilities, rise in adoption of blepharoplasty surgery and the growth in demand for cosmetic surgery for eyelid rejuvenation. However, Asia-Pacific is expected to exhibit the fastest growth during the forecast period, owing to increase in number of patients undergoing eyelid surgery, high population base, and surge in healthcare expenditure. 

Author Name(s) : Shubham Sharma | Roshan Deshmukh

Related Tags

• Surgical Equipment
• Aesthetics
• Assistive Devices
• Opthalmology